PRemature Acute Myocardial Infarction Register of Serbia
PRAMIRS
Clinical Characteristics and Outcomes of Patients with Premature Acute Myocardial Infarction in Serbia - a Multicenter National Study
1 other identifier
observational
1,000
1 country
11
Brief Summary
This observational multicentric national study aims to understand better acute myocardial infarction (heart attack) in young adults aged 45 years or younger in Serbia. By analyzing patient characteristics, medical history, test results, and treatment outcomes, the research seeks to identify factors contributing to heart attacks in this population and improve prevention and treatment strategies. Participants will undergo routine tests during hospitalization, and specific blood samples will be collected for advanced analyses, including genetic testing. Follow-up will include periodic check-ins to monitor health outcomes. The study will also explore differences in heart attack causes and outcomes in younger individuals compared to older populations, focusing on risk factors like smoking, cholesterol levels, and genetic predisposition. Participation is voluntary, and all collected data will remain confidential.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2024
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 25, 2024
CompletedFirst Submitted
Initial submission to the registry
December 18, 2024
CompletedFirst Posted
Study publicly available on registry
December 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 25, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 25, 2026
December 31, 2024
December 1, 2024
2 years
December 18, 2024
December 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Incidence and Prevalence of AMI in Patients Aged ≤ 45 Years in Serbia
The incidence and prevalence of AMI among patients aged ≤ 45 years in Serbia will be reported over the study period, expressed as the number of new and existing cases per 100,000 individuals annually Unit of Measure: "Cases per 100,000 individuals per year."
From 01.January 2021.year to 31.December 2026.
Demographic Characteristics and Prevalence of Atherosclerotic Risk Factors in Young AMI Patients
The demographic distribution (e.g., age, gender, socioeconomic status) and prevalence of standard atherosclerotic risk factors (e.g., smoking, diabetes, hypertension, hyperlipidemia) among AMI patients aged ≤ 45 years will be analyzed. Unit of Measure: "Percent of participants with each risk factor."
From 01.January 2021.year to 31.December 2026.
Angiographic Characteristics in Young AMI Patients
The presence and extent of obstructive and non-obstructive coronary artery disease, coronary lesions, dissection, and vasospasm will be assessed using angiographic findings. Unit of Measure: "Percent of participants with each angiographic characteristic."
From 01.January 2021.year to 31.December 2026.
Secondary Outcomes (8)
Characteristics of Atherosclerotic Plaque Using OCT or IVUS
From 01.January 2021.year to 31.December 2026.
Prevalence of SCAD in Young AMI Patients
From 01.January 2021.year to 31.December 2026.
Prevalence of Comorbidities in Young AMI Patients
From 01.January 2021.year to 31.December 2026.
Prevalence of Inherited or Acquired Thrombophilia in MINOCA Patients
From 01.January 2021.year to 31.December 2026.
Prevalence of Familial Hypercholesterolemia in Young AMI Patients
From 01.January 2021.year to 31.December 2026.
- +3 more secondary outcomes
Eligibility Criteria
This national, multicentric, retrospective and prospective analysis would include patients with acute myocardial infarction (AMI) aged ≤ 45 years in Serbia
You may qualify if:
- Patients aged ≤ 45 years. Clinical and laboratory diagnosis of acute myocardial infarction (AMI) based on the Universal Definition of Myocardial Infarction.
- Voluntary participation with signed informed consent.
You may not qualify if:
- Patients aged \> 45 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (11)
Military Medical Academy 1
Belgrade, 11000, Serbia
University Hospital Center Zvezdara
Belgrade, 11000, Serbia
University Hospital Center Bezanijska kosa
Belgrade, 11080, Serbia
University Hospital Center Zemun
Belgrade, 11080, Serbia
Military Medical Academy 2
Belgrade, Serbia
General Hospital Studenica
Kraljevo, 36000, Serbia
University Clinical Center Nis
Niš, 18000, Serbia
Institute for cardiovascular diseases Vojvodina
Novi Sad, 21000, Serbia
General Hospital Prokuplje
Prokuplje, 18400, Serbia
General Hospital Vrbas
Vrbas, 21460, Serbia
General Hospital Zrenjanin
Zrenjanin, 23000, Serbia
Biospecimen
Frozen samples for the potential substudies on genetics and non-standard laboratory analysis
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aleksandra Djokovic, MD, PhD
Cardiology Society of Serbia, Belgrade, Serbia
- PRINCIPAL INVESTIGATOR
Svetlana Apostolovic, Md, PhD
Cardiology Society of Serbia, Belgrade, Serbia
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 18, 2024
First Posted
December 31, 2024
Study Start
September 25, 2024
Primary Completion (Estimated)
September 25, 2026
Study Completion (Estimated)
September 25, 2026
Last Updated
December 31, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- From 30.December 2026
- Access Criteria
- Principal Investigators of other national registries involving AIM in young adults
For the purposes of meta statistical analysis